Prepared For

Ms Purvi Sharma
F 24
fa lse

Name Patient ID Gender Age

Ms Purvi Sharma 6681607 F 24

Health Summary

BLOOD COUNTS

Test Name Result

THYROID PROFILE
RBC count 3.5

Total Leukocyte Count 10.3 Everything looks good

Abs. Lymphocyte Count 3.91

Please Watchout

LIPID PROFILE

Test Name Result DIABETES MONITORING

HDL Cholesterol 34.9
Everything looks good
Total Cholesterol : HDL ratio 5.13
Please Watchout

KIDNEY PROFILE LIVER PROFILE

Everything looks good Test Name Result

ALP 166.0
Please Watchout

ANEMIA STUDIES

ELECTROLYTES Test Name Result

RDW-SD 67.4
Everything looks good
RDW-CV 17.1

MCH 36.5
+ 2 tests Please Watchout

MINERAL PROFILE

Test Name Result

Iron 31.6
Please Watchout
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Whole blood EDTA Report Date : Dec 31, 2023, 11:47 AM
Barcode No : HX826085 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

HEMATOLOGY REPORT
Fit India Full Body Checkup
Complete Blood Count (CBC)
RBC PARAMETERS
Hemoglobin 12.7 g/dL 12.0 - 15.0
Method : colorimetric
RBC Count 3.5 10^6/µl 3.8 - 4.8
Method : Electrical impedance
PCV 38.3 % 36 - 46
Method : Calculated
MCV 110.4 fl 83 - 101
Method : Calculated
MCH 36.5 pg 27 - 32
Method : Calculated
MCHC 33.1 g/dL 31.5 - 34.5
Method : Calculated
RDW (CV) * 17.1 % 11.6 - 14.0
Method : Calculated
RDW-SD * 67.4 fl 35.1 - 43.9
Method : Calculated
WBC PARAMETERS
TLC 10.3 10^3/µl 4 - 10
Method : Electrical impedance and microscopy
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils 55.1 % 40-80
Lymphocytes 38 % 20-40
Monocytes 5.5 % 2-10
Eosinophils 1.2 % 1-6
Basophils 0.2 % <2
Absolute leukocyte counts
Method : Calculated
Neutrophils. 5.68 10^3/µl 2-7
Lymphocytes. 3.91 10^3/µl 1-3
Monocytes. 0.57 10^3/µl 0.2 - 1.0
Eosinophils. 0.12 10^3/µl 0.02 - 0.5
Basophils. 0.02 10^3/µl 0.02 - 0.5
PLATELET PARAMETERS
Platelet Count 292 10^3/µl 150 - 410
Method : Electrical impedance and microscopy
Mean Platelet Volume (MPV) * 10.5 fL 9.3 - 12.1
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 1 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Whole blood EDTA Report Date : Dec 31, 2023, 11:47 AM
Barcode No : HX826085 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

Method : Calculated
PCT * 0.3 % 0.17 - 0.32
Method : Calculated
PDW * 12.1 fL 8.3 - 25.0
Method : Calculated
P-LCR * 30.2 % 18 - 50
Method : Calculated
P-LCC * 88 % 44 - 140
Method : Calculated
Mentzer Index * 31.54 % -
Method : Calculated

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 2 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Whole blood EDTA Report Date : Dec 31, 2023, 01:15 PM
Barcode No : HX826085 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

HEMATOLOGY REPORT
Fit India Full Body Checkup
Erythrocyte Sedimentation Rate (ESR)
ESR - Erythrocyte Sedimentation Rate 69 mm/hr 0-22
Method : Modified Westergren

Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.

AGE MALE FEMALE

1 DAY 0-12 0-12
2 - 7 DAYS 0-4 0-4
8 - 14 DAYS 0-17 0-17
15 DAYS - 17 YEARS 0-20 0-20
18 - 50 YEARS 0-10 0-12
51- 60 YEARS 0-12 0-19
61 - 70 YEARS 0-14 0-20
71 - 100 YEARS 0-30 0-35

Reference- Dacie and lewis practical hematology

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 3 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Whole blood EDTA Report Date : Dec 31, 2023, 12:07 PM
Barcode No : HX826085 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

HEMATOLOGY REPORT
Fit India Full Body Checkup
HbA1C (Glycosylated Haemoglobin)
GLYCOSYLATED HEMOGLOBIN (HbA1c) 5.5 % < 5.7
Method : HPLC
ESTIMATED AVERAGE GLUCOSE * 111.15 mg/dL Refer Table Below

Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 %
may not be appropriate.

Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as
compared to blood and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 4 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Whole blood EDTA Report Date : Dec 31, 2023, 12:07 PM
Barcode No : HX826085 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 5 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : FLUORIDE F Report Date : Dec 31, 2023, 12:24 PM
Barcode No : ZA927239 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Glucose Fasting (BSF)
GLUCOSE FASTING 92.8 mg/dL 70 - 100
Method : Hexokinase

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels
(hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders.
Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 6 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Serum Report Date : Dec 31, 2023, 01:25 PM
Barcode No : ZA927240 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Liver Function Test (LFT)
BILIRUBIN TOTAL 0.3 mg/dL 0 - 1.2
Method : Colorimetric Diazo
BILIRUBIN DIRECT * 0.1 mg/dL 0 - 0.20
BILIRUBIN INDIRECT * 0.2 mg/dL 0.1 - 1.0
Method : Calculation (T Bil - D Bil)
SGOT/AST 16.6 U/L up to 40
Method : IFCC without P5P
SGPT/ALT 16.7 U/L up to 41
Method : IFCC without P5P
SGOT/SGPT Ratio * 0.99 - -
ALKALINE PHOSPHATASE 166.0 U/L 35 - 104
Method : IFCC
TOTAL PROTEIN 7.5 g/dL 6.0 - 7.8
Method : Biuret
ALBUMIN 4.5 g/dL 3.5 - 5.2
Method : Colorimetric
GLOBULIN * 3.0 g/dL 2.3 - 3.5
Method : Calculation (T.P - Albumin)
ALBUMIN : GLOBULIN RATIO * 1.5 - 1.0 - 2.1
Method : Calculation (Albumin/Globulin)
GAMMA GLUTAMYL TRANSFERASE (GGT) * 16.6 U/L 5-40
Method : ENZYMATIC

Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood clotting proteins, and
performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical reactions. When liver cells are damaged or
destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood tests Liver tests check the blood for two main liver enzymes. Aspartate
aminotransferase (AST),SGOT: The AST enzyme is also found in muscles and many other tissues besides the liver. Alanine aminotransferase (ALT), SGPT: ALT is
almost exclusively found in the liver. If ALT and AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline Phosphatase
and GGT: Another of the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes (ducts), and is
eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise: Alkaline phosphatase Gamma-utamyl
transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is by far the most commonly tested of the three. If
alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile flow problems can be due to a problem in the liver, the gallbladder, or
the tubes connecting them. Proteins are important building blocks of all cells and tissues. Proteins are necessary for your body's growth, development, and health. Blood
contains two classes of protein, albumin and globulin. Albumin proteins keep fluid from leaking out of blood vessels. Globulin proteins play an important role in your
immune system. Low total protein may indicate: 1.bleeding 2.liver disorder 3.malnutrition 4.agammaglobulinemia High Protein levels 'Hyperproteinemia: May be seen
in dehydration due to inadequate water intake or to excessive water loss (eg, severe vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased
production of proteins Low albumin levels may be caused by: 1.A poor diet (malnutrition). 2.Kidney disease. 3.Liver disease. High albumin levels may be caused by:
Severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 7 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Serum Report Date : Dec 31, 2023, 01:25 PM
Barcode No : ZA927240 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Kidney Function Test (KFT)
BLOOD UREA 22.7 mg/dL 16.6 - 48.5
Method : Urease
CREATININE 0.6 mg/dL 0.50 - 0.90
Method : Jaffe
BUN * 10.61 mg/dL 6 - 20
Method : Urease
BUN/CREATININE RATIO * 17.68
UREA / CREATININE RATIO * 37.83
URIC ACID 4.9 mg/dL 2.4 - 5.7
Method : Enzymatic colorimetric
CALCIUM Serum 9.0 mg/dL 8.6 - 10.0
Method : BAPTA
PHOSPHORUS 3.7 mg/dL 2.5 - 4.5
Method : Molybdate UV
SODIUM 143.5 mmol/L 136 - 145
Method : ISE-Indirect
POTASSIUM 5.0 mmol/L 3.5 - 5.1
Method : ISE-Indirect
CHLORIDE 107.0 mmol/L 98 - 107
Method : ISE-Indirect

Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual
(chronic) declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may
indicate a problem with your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful
urination,swelling in the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring
simultaneously, these symptoms suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes
(sodium,potassium,and chloride) are present in the human body and the balancing act of the electrolytes in our bodies is essential for normal function of our cells
and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or parathyroid disease. The test may also be done to monitor progress
and treatment of these diseases.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 8 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Serum Report Date : Dec 31, 2023, 01:25 PM
Barcode No : ZA927240 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Lipid Profile
TOTAL CHOLESTEROL 179.0 mg/dL Desirable : <200
Method : Enzymatic - Cholesterol Oxidase Borderline : 200-239
High : >240
TRIGLYCERIDES 104.0 mg/dL Normal : <150
Method : Colorimetric - Lip/Glycerol Kinase Borderline : 150-199
High : 200-499
Very high : >500
HDL CHOLESTEROL 34.9 mg/dL No Risk >55
Method : Enzymatic colorimetric Moderate risk 35-55
High risk <35.0
NON HDL CHOLESTEROL * 144.1 mg/dL <130
Method : Calculated
LDL CHOLESTEROL * 123.3 mg/dL Optimal <100
Method : Calculated Near optimal/above optimal
100-129 Borderline high
130-159
High 160-189
Very high =190
V.L.D.L CHOLESTEROL * 20.8 mg/dL < 30
Method : Calculated
CHOL/HDL Ratio * 5.13 - 3.5 - 5.0
Method : Calculated
HDL/ LDL RATIO * 0.28 - Desirable : 0.5 - 3.0
Method : Calculated
Borderline : 3.1 - 6.0

High : > 6.0

LDL/HDL Ratio * 3.53 - -
Method : Calculated

Note: Kindly correlate clinically.

Advice: Repeat if clinically indicated.

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 9 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Serum Report Date : Dec 31, 2023, 01:25 PM
Barcode No : ZA927240 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

Borderline High 200-239 150-199 130-159 160 - 189

High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors

Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors

1. Age >/=45 years in Males &

3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)
Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 10 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Serum Report Date : Dec 31, 2023, 01:25 PM
Barcode No : ZA927240 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 11 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Serum Report Date : Dec 31, 2023, 01:25 PM
Barcode No : ZA927240 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Iron Studies
IRON 31.6 µg/dL 33 - 193
Method : FerroZine
TIBC,(Total Iron Binding Capacity) 369.6 µg/dL 158 - 538
Method : Method :Spectrophotometric Assay
UIBC 338 µg/dL 135 - 392
Method : FerroZine
TRANSFERRIN SATURATION 8.55 % 15 - 50
Method : Method :Derived from IRON and TIBC values

Interpretation:
Increased levels due to iron ingestion or ineffective erythropoiesis.Decreased levels due to infection, inflammation, malignancy, menstruation and
Fe deficiency.Needs to be taken into consideration with TIBC. Transferrin Saturation:- Low level Transferrin Saturation can indicate iron
deficiency, erythropoiesis, infection, or inflammation. High level Transferrin Saturation can indicate recent ingestion of dietary iron,ineffective
erythropoiesis,haemochromatosis or liver disease.High TIBC, UIBC, or transferrin usually indicates iron deficiency, but they are also increased in
pregnancy and with the use of oral contraceptives. Low TIBC, UIBC, or transferrin may occur if someone has:Hemochromatosis, Certain types of
anemia due to accumulated iron,Malnutrition,kidney disease that causes a loss of protein in urine.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 12 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Serum Report Date : Dec 31, 2023, 12:24 PM
Barcode No : ZA927240 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Thyroid Profile Total
TRIIODOTHYRONINE ( T3 ) 1.33 ng/mL 0.71 - 2.01
Method : ECLIA
TOTAL THYROXINE ( T4 ) 9.5 µg/dL 5.1 - 14.1
Method : ECLIA
THYROID STIMULATING HORMONE (Ultrasensitive) 3.41 µIU/mL 0.27 - 4.20
Method : ECLIA

Interpretation:
Primary malfunction of the thyroid gland may result in excessive (hyper) or below normal (hypo) release of T3 or T4. In addition as TSH directly
affects thyroid function, malfunction of the pituitary or the hypo - thalamus influences the thyroid gland activity. Disease in any portion of the
thyroid-pitutary-hypothala- mus system may influence the levels of T3 and T4 in the blood. In primary hypothyroidism, TSH levels are
significantly elevated, while in secondary and tertiary hypothyroidism, TSH levels may be low. In addition, in the Euthyroid Sick Syndrome,
multiple alterations in serum thyroid function test findings have been recognized in patients with a wide variety of non-thyroidal illnesses (NTI)
without evidence of preexisting thyroid or hypothalami c-pitutary diseases. Thyroid Binding Globulin (TBG) concentrations remain relatively
constant in healthy individuals. However, pregnancy, excess estrogen's, androgen's, antibiotic steroids and glucocorticoids are known to alter
TBG levels and may cause false thyroid values for Total T3 and T4 tests.
TSH T4 T3 INTERPRETATION
High Normal Normal Mild (subclinical) hypothyroidism
Low or
High Low Hypothyroidism
normal
Low Normal Normal Mild (subclinical) hyperthyroidism
High or High or
Low Hyperthyroidism
normal normal
Low or Low or
Low Nonthyroidal illness; pituitary (secondary) hypothyroidism
normal normal
Thyroid hormone resistance syndrome (a mutation in the thyroid hormone receptor decreases thyroid
Normal High High
hormone function)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 13 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Jan 01, 2024, 06:32 AM
Sample Type : Serum Report Date : Jan 01, 2024, 01:22 PM
Barcode No : SI376302 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

SEROLOGY AND IMMUNOLOGY REPORT

HIV 1&2 Antibody, Quantitative
HIV I & II Quantitative & P24 COMBO 0.1 S/CO <1.00 :Nonreactive
Method : CMIA >1.00 :Reactive
Interpretation:
The cutoff is 1.00 S/CO.

S/CO Reference Ranges

< 1.00 Nonreactive
≥ 1.00 Reactive

Final Interpretation
Initial Interpretation Results with Retes Final Interpretation
Nonreactive. HIV p24 Ag and/or HIV-1/HIV-2 Ab not
Nonreactive No retest required
detected.
Nonreactive. HIV p24 Ag and/or HIV-1/HIV-2 Ab not
If both retest results are < 1.00 detected
Reactive
Reactive. Presumptive evidence of HIV p24 Ag
If one or both retest results are ≥ 1.00 and/or HIV-1/ HIV-2 Ab; perform a supplemental
assay

1. Non-Reactive result implies that no Anti HIV-I OR HIV-II Antibodies have been detected in the sample by this method. This means that either
the patient has not exposed to HIV-I or HIV-II infection or the sample has been tested during the "WINDOW PHASE"(before the development of
detectable levels of antibodies). Hence negative result does not exclude the possibility of exposure to or infection with HIV-I/HIV-II.
2. Immunoassay for the in vitro qualitative determination of HIV-1 p24 antigen and antibodies to HIV-1, including group O, and HIV-2 in human
serum
3. It is a screening test and reactive samples need to confirmed by alternate method like western blot or PCR

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H-55, Sector-63, Noida, Uttar Pradesh - 201301

Page 14 of 15
 Patient Name : Ms Purvi Sharma
DOB/Age/Gender : 24 Y/Female Bill Date : Dec 30, 2023, 06:54 PM
Patient ID / UHID : 6681607/RCL5738186 Sample Collected : Dec 31, 2023, 10:14 AM
Referred By : Dr. Sample Received : Dec 31, 2023, 11:17 AM
Sample Type : Spot Urine Report Date : Dec 31, 2023, 12:38 PM
Barcode No : YA079789 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

CLINICAL PATHOLOGY REPORT

Fit India Full Body Checkup
Urine Routine and Microscopic Examination
PHYSICAL EXAMINATON
Volume * 15 mL -
Colour * Pale yellow - Pale yellow
Transparency * Slightly Hazy - Clear
Deposit * Absent - Absent
CHEMICAL EXAMINATION
Reaction (pH) 5.0 - 4.5 - 8.0
Method : Double Indicator
Specific Gravity 1.030 - 1.010 - 1.030
Method : Ion Exchange
Urine Glucose (sugar) Negative - Negative
Urine Protein (Albumin) Negative - Negative
Urine Ketones (Acetone) Negative - Negative
Blood Positive(Trace) - Negative
Leucocyte esterase Negative - Negative
Bilirubin Urine Negative - Negative
Nitrite Negative - Negative
Method : Griless Test
Urobilinogen Normal - Normal
Method : Ehrlichs Test
MICROSCOPIC EXAMINATION
Pus Cells (WBCs) * 2-4 /hpf 0-5
Epithelial Cells * 12-15 /hpf 0-4
Red blood Cells * 3-5 /hpf Absent
Crystals * Absent - Absent
Cast * Absent - Absent
Yeast Cells * Absent - Absent
Amorphous deposits * Absent - Absent
Bacteria * Absent - Absent
Protozoa * Absent - Absent

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- HOME COLLECTION - DEHRADUN - F10180

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 41/2, Pocket No.2, Vivek Vihar, GMS Road, Dehradun-248001

Page 15 of 15
 Terms and Conditions of Reporting

1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.

2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.

3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.

4. This report shall not be deemed valid or admissible for any medico-legal purposes.

5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.
 Name Patient ID Gender Age
fa lse

Ms Purvi Sharma 6681607 F 24

Health Advisory
Normal (N) Low (L) Borderline (BL) High (H)

Lipid Profile
This panel measures the amount of lipoprotein - a type of fat required to produce energy in your body. Too much fat
restricts oxygen ow to your heart, which may lead to heart disease.

HDL Cholesterol: 34.9 mg/dL LOW

LOW NORMAL

< 40 > 40
You: 34.9

Diet and Lifestyle Tips :

If you smoke, find a way to

Besides helping you lose
Limit saturated fat, found in quit. Smoking lowers HDL
weight, increased physical
meats and full-fat dairy levels, especially in women,
activity can increase your
products, as well. and increases LDL levels and
HDL levels.
triglyceride.
+ +
SMART HEALTH REPORT
RT
MC-5280

About Redcliffe Labs

We
Weare
are
India’s
India’sMost
Most Trusted
Trusted &&Fastest
FastestGrowing
GrowingNetwork
Networkof Diagnostic
of Diagnostics
Centres
Labs

Best Customer Quality Commitment Affordable Prices

+
Experience With Accurate Reports With Quick Results

Commitment to excellence, Focus on quality with Value for money with

high end technology oriented staff accurate results quick turn around time (TAT)

Select from a wide range of

Full Body Health Check-up

packages that suits your health

Best Selling Package

Advance Full Body Check-up

Download our app & get

Free report consultation

A Simple and easy way to track your health

3500 + Tests & Packages Home Sample Collection or Visit

Nearest Collection Centre

Access Smart Reports Presence in 150+ Cities